Top 100 medical and healthcare startups in Israel
Feb 11, 2026
|
Like
18
1
Funding: $1B
Novocure is developing a new treatment for solid tumors known as tumor polytherapy (TTFields). TTFields are low-intensity alternating electric fields, particularly at intermediate frequencies that disrupt cancer cell division through physical interaction with key molecules during mitosis. TTFields do significantly affect healthy cells, as they have different properties (including division rate, morphology and electrical properties) compared to cancer cells. The company's TTFields pipeline includes therapies against glioblastoma, metastatic non-small cell lung cancer and pancreatic cancer. The company also produces FDA-approved portable devices for the treatment of GB and mNSCLC. These devices also work via creating electric fields that can slow or stop cancer cell division.
Novocure is developing a new treatment for solid tumors known as tumor polytherapy (TTFields). TTFields are low-intensity alternating electric fields, particularly at intermediate frequencies that disrupt cancer cell division through physical interaction with key molecules during mitosis. TTFields do significantly affect healthy cells, as they have different properties (including division rate, morphology and electrical properties) compared to cancer cells. The company's TTFields pipeline includes therapies against glioblastoma, metastatic non-small cell lung cancer and pancreatic cancer. The company also produces FDA-approved portable devices for the treatment of GB and mNSCLC. These devices also work via creating electric fields that can slow or stop cancer cell division.
2
Funding: $414M
AIdoc helps radiologists work through their case load faster, just in time to make a difference. We reworked deep learning algorithms to analyze imaging and clinical data more effectively, and can produce highly accurate scan anomaly detection. We combine the analyzed scans with patient data, streamlining the radiologists' workflow and freeing them to do what they do best.
AIdoc helps radiologists work through their case load faster, just in time to make a difference. We reworked deep learning algorithms to analyze imaging and clinical data more effectively, and can produce highly accurate scan anomaly detection. We combine the analyzed scans with patient data, streamlining the radiologists' workflow and freeing them to do what they do best.
3
Funding: $274M
Nanox Medical researches and develops breakthrough X-ray technology that generates unique monochromatic X-rays with very high fluency.
Nanox Medical researches and develops breakthrough X-ray technology that generates unique monochromatic X-rays with very high fluency.
4
Funding: $225.6M
Augmedics develops cutting-edge technologies for future surgery. Augmedics develops a smart surgical system - The ViZOR: An Augmented Reality Head Mounted Display equipped with various sensors and machine learning capabilities, to be the enabling technology for future surgery.
Augmedics develops cutting-edge technologies for future surgery. Augmedics develops a smart surgical system - The ViZOR: An Augmented Reality Head Mounted Display equipped with various sensors and machine learning capabilities, to be the enabling technology for future surgery.
5
Funding: $226.3M
Carbyne is a national emergency communication platform, running the most advanced technology for emergency infrastructure.
Carbyne is a national emergency communication platform, running the most advanced technology for emergency infrastructure.
6
Funding: $218.2M
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
7
Funding: $205.7M
A disruptive mobile-health AI-powered platform and device, allowing anyone to perform self physical examination and remote diagnosis.
A disruptive mobile-health AI-powered platform and device, allowing anyone to perform self physical examination and remote diagnosis.
8
Funding: $190M
ForSight Robotics created surgical platform designed specifically for ophthalmological (eye) surgeries — a category requiring a great deal of precision.
ForSight Robotics created surgical platform designed specifically for ophthalmological (eye) surgeries — a category requiring a great deal of precision.
9
Funding: $185M
Healthy.io de Dip.io, a home-based urinalysis kit that turns a smartphone into a clinical-grade diagnostic device. It’s the first smartphone-based urine test to secure clearance as a Class 2 device.
Healthy.io de Dip.io, a home-based urinalysis kit that turns a smartphone into a clinical-grade diagnostic device. It’s the first smartphone-based urine test to secure clearance as a Class 2 device.
10
Funding: $179M
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).
11
Funding: $149.7M
LifeBeam creates headphones VI that come with incredible sound and real time fitness coaching.
LifeBeam creates headphones VI that come with incredible sound and real time fitness coaching.
12
Funding: $130M
OrCam’s mission is to harness the power of artificial vision by incorporating pioneering technology into a wearable platform which improves the lives of individuals who are blind, visually impaired, and have reading difficulties. OrCam has created a technologically advanced device unique in its ability to provide visual aid through a discreet wearable platform and simple easy-to-use interface which serves to enhance the daily lives of people with vision loss.
OrCam’s mission is to harness the power of artificial vision by incorporating pioneering technology into a wearable platform which improves the lives of individuals who are blind, visually impaired, and have reading difficulties. OrCam has created a technologically advanced device unique in its ability to provide visual aid through a discreet wearable platform and simple easy-to-use interface which serves to enhance the daily lives of people with vision loss.
13
Funding: $128M
Memic has set out to transform robotic-assisted surgery, with proprietary technology that has the potential to far surpasses today’s best solutions. Providing unprecedented access and maneuverability, our Memic’s Hominis surgical platform features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation.
Memic has set out to transform robotic-assisted surgery, with proprietary technology that has the potential to far surpasses today’s best solutions. Providing unprecedented access and maneuverability, our Memic’s Hominis surgical platform features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation.
14
Funding: $126M
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
15
Funding: $125.1M
Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology.
Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology.
16
Funding: $123.8M
Sight Diagnostics aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving healthcare for all. Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology.
Sight Diagnostics aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving healthcare for all. Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology.
17
Funding: $118.5M
Ibex is pioneering AI-based cancer diagnostics in pathology. Its Galen platform uses AI-based algorithms to analyze images, detect and grade cancer in biopsies, helping pathologists reduce diagnostic error rates and enable a more efficient workflow.
Ibex is pioneering AI-based cancer diagnostics in pathology. Its Galen platform uses AI-based algorithms to analyze images, detect and grade cancer in biopsies, helping pathologists reduce diagnostic error rates and enable a more efficient workflow.
18
Funding: $104M
MDClone offers a new heatlhcare data paradigm, enabling fast and direct access to healthcare data while fully protecting patient’s privacy.
MDClone offers a new heatlhcare data paradigm, enabling fast and direct access to healthcare data while fully protecting patient’s privacy.
19
Funding: $101.5M
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
20
Funding: $100M
CytoReason is an AI company developing a computational model of the human body, accurate enough to start replacing animal and human trials in drug development.
CytoReason is an AI company developing a computational model of the human body, accurate enough to start replacing animal and human trials in drug development.
21
Funding: $99M
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
22
Funding: $94.5M
Nym Health is developing auditable machine learning tools for automating hospital billing.
Nym Health is developing auditable machine learning tools for automating hospital billing.
23
Funding: $93.7M
The first in-home virtual care agent, leveraging AI to enable home care agencies to offer 24/7 services.
The first in-home virtual care agent, leveraging AI to enable home care agencies to offer 24/7 services.
24
Funding: $86M
Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
25
Funding: $85.5M
Brainsway has revolutionized brain disorder treatment, with Brainsway Deep TMS therapy, or Deep Transcranial Magnetic Stimulation. With Brainsway Deep TMS, patients can regain wellbeing, calm and happiness in just a few weeks.
Brainsway has revolutionized brain disorder treatment, with Brainsway Deep TMS therapy, or Deep Transcranial Magnetic Stimulation. With Brainsway Deep TMS, patients can regain wellbeing, calm and happiness in just a few weeks.
26
Funding: $83M
Nucleix is developing liquid biopsy technology for the early detection of cancer. Its first product - Bladder EpiCheck test is certified for the diagnosis of primary and recurrent bladder and upper urinary tract cancer. This in vitro diagnostic device detects DNA methylation patterns in urine associated with urothelial carcinoma. It is intended for use as non-invasive method for monitoring tumor recurrence in conjunction with standard diagnostic procedures. The test analyzes small, disease-specific changes in DNA methylation markers, enabling the detection of cancer. The test has demonstrated high sensitivity (91%) for high-grade tumors, which are important to detect because they are aggressive and, if not treated immediately, can progress to invasive cancer. The company is also developing Lung EpiCheck to detect lung cancer at an early stage in high-risk individuals using a simple blood test.
Nucleix is developing liquid biopsy technology for the early detection of cancer. Its first product - Bladder EpiCheck test is certified for the diagnosis of primary and recurrent bladder and upper urinary tract cancer. This in vitro diagnostic device detects DNA methylation patterns in urine associated with urothelial carcinoma. It is intended for use as non-invasive method for monitoring tumor recurrence in conjunction with standard diagnostic procedures. The test analyzes small, disease-specific changes in DNA methylation markers, enabling the detection of cancer. The test has demonstrated high sensitivity (91%) for high-grade tumors, which are important to detect because they are aggressive and, if not treated immediately, can progress to invasive cancer. The company is also developing Lung EpiCheck to detect lung cancer at an early stage in high-risk individuals using a simple blood test.
27
Funding: $83M
Intuition Robotics provides care companion technologies for older adults.
Intuition Robotics provides care companion technologies for older adults.
28
Funding: $79.3M
Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data.
Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data.
29
Funding: $79M
TailorMed, a platform that allows healthcare providers to manage their finances, check health plans and estimate out-of-pocket costs for uninsured patients
TailorMed, a platform that allows healthcare providers to manage their finances, check health plans and estimate out-of-pocket costs for uninsured patients
30
Funding: $71.9M
Aligning incentives between payers and healthcare providers to enable value-based care decisions.
Aligning incentives between payers and healthcare providers to enable value-based care decisions.
31
Funding: $72M
Ayala Pharmaceuticals develops a personalized treatment for cancer.
Ayala Pharmaceuticals develops a personalized treatment for cancer.
33
Funding: $69.3M
Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.
Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.
34
Funding: $69M
Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients that uses AI and predictive analytics models to solve a global challenge: strained health budgets and workforces.
Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients that uses AI and predictive analytics models to solve a global challenge: strained health budgets and workforces.
35
Funding: $65M
NeoTX Therapeutics is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy.
NeoTX Therapeutics is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy.
36
Funding: $63.1M
BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).
BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).
37
Funding: $60.5M
Nucleai aims to Improve cancer diagnostics making it accurate, effective, accessible and efficient in order to treat patients better by using Machine Learning, Deep Learning, and Machine Vision technology.
Nucleai aims to Improve cancer diagnostics making it accurate, effective, accessible and efficient in order to treat patients better by using Machine Learning, Deep Learning, and Machine Vision technology.
38
Funding: $60.3M
Flytrex develops drone delivery systems that simplify deliveries and enhance efficiency by shortening delivery times and lowering costs.
Flytrex develops drone delivery systems that simplify deliveries and enhance efficiency by shortening delivery times and lowering costs.
39
Funding: $59M
BioSight is a biopharmaceutical company revolutionizing the research and development of innovative cancer targeted pro-drugs. BioSight has developed technology S2DOT TM and a pipeline of targeted pro-drugs, that can target and release chemotherapy drugs inside cancer cells, while significantly minimizing the systemic toxicity associated with conventional chemotherapy treatments.
BioSight is a biopharmaceutical company revolutionizing the research and development of innovative cancer targeted pro-drugs. BioSight has developed technology S2DOT TM and a pipeline of targeted pro-drugs, that can target and release chemotherapy drugs inside cancer cells, while significantly minimizing the systemic toxicity associated with conventional chemotherapy treatments.
40
Funding: $55.4M
OncoHost is developing cutting-edge technology to characterize, analyze, and predict patient response to treatment, enabling personalized treatment strategies with improved outcomes & reduced side effects.
OncoHost is developing cutting-edge technology to characterize, analyze, and predict patient response to treatment, enabling personalized treatment strategies with improved outcomes & reduced side effects.
41
Funding: $51.5M
Medisafe is the leading Personalized Medication Management Platform helping patients stay on top of all their medications.
Medisafe is the leading Personalized Medication Management Platform helping patients stay on top of all their medications.
42
Funding: $50.5M
DOT Compliance delivers the industry's first ready to use cloud-based quality and compliance management solution for regulated industries.
DOT Compliance delivers the industry's first ready to use cloud-based quality and compliance management solution for regulated industries.
43
Funding: $50.9M
Air doctor is a simple online marketplace of verified and professional private practitioners made for travelers, who can now independently and easily choose a medical provider to treat them; just as if they were back at home.
Air doctor is a simple online marketplace of verified and professional private practitioners made for travelers, who can now independently and easily choose a medical provider to treat them; just as if they were back at home.
44
Funding: $48.8M
BrainQ is developing Artificial Intelligence-powered technologies to treat neuro-disorders in innovative ways.
BrainQ is developing Artificial Intelligence-powered technologies to treat neuro-disorders in innovative ways.
45
Funding: $44.5M
Our mission is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from H&E image. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients.
Our mission is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from H&E image. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients.
46
Funding: $42.5M
Theator is a surgical intelligence platform that combines artificial intelligence and computer vision to improve surgeon performance.
Theator is a surgical intelligence platform that combines artificial intelligence and computer vision to improve surgeon performance.
47
Funding: $38.1M
EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.
EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.
48
Funding: $35.5M
Sweetch uses artificial intelligence to help patients manage chronic conditions
Sweetch uses artificial intelligence to help patients manage chronic conditions
49
Funding: $33M
Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications.
Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications.
50
Funding: $32M
Medasense's NOL® AI technology and sensing platform quantifies pain response to personalize and optimize pain management.
Medasense's NOL® AI technology and sensing platform quantifies pain response to personalize and optimize pain management.
